SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

SEC Comment Letter 0000000000-24-008742 to PALATIN TECHNOLOGIES INC (PTN)

PALATIN TECHNOLOGIES INC
Date: July 31, 2024 · CIK: 0000911216 · Accession: 0000000000-24-008742

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-281007

Date
July 31, 2024
Author
Carl Spana
Form
UPLOAD
Company
PALATIN TECHNOLOGIES INC

Letter

July 31, 2024 Carl Spana Chief Executive Officer Palatin Technologies, Inc. 4B Cedar Brook Drive Cranbury, NJ 08512 Re:Palatin Technologies, Inc. Registration Statement on Form S-1 Filed July 25, 2024 File No. 333-281007 Dear Carl Spana: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Lauren Hamill at 303-844-1008 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Faith Charles

Show Raw Text
July 31, 2024
Carl Spana
Chief Executive Officer
Palatin Technologies, Inc.
4B Cedar Brook Drive
Cranbury, NJ 08512
Re:Palatin Technologies, Inc.
Registration Statement on Form S-1
Filed July 25, 2024
File No. 333-281007
Dear Carl Spana:
            This is to advise you that we have not reviewed and will not review your registration
statement.
            Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that
the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
            Please contact Lauren Hamill at 303-844-1008 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Faith Charles